505 related articles for article (PubMed ID: 24135427)
1. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
2. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
3. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
4. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled trial of oral propranolol in infantile hemangioma.
Léauté-Labrèze C; Hoeger P; Mazereeuw-Hautier J; Guibaud L; Baselga E; Posiunas G; Phillips RJ; Caceres H; Lopez Gutierrez JC; Ballona R; Friedlander SF; Powell J; Perek D; Metz B; Barbarot S; Maruani A; Szalai ZZ; Krol A; Boccara O; Foelster-Holst R; Febrer Bosch MI; Su J; Buckova H; Torrelo A; Cambazard F; Grantzow R; Wargon O; Wyrzykowski D; Roessler J; Bernabeu-Wittel J; Valencia AM; Przewratil P; Glick S; Pope E; Birchall N; Benjamin L; Mancini AJ; Vabres P; Souteyrand P; Frieden IJ; Berul CI; Mehta CR; Prey S; Boralevi F; Morgan CC; Heritier S; Delarue A; Voisard JJ
N Engl J Med; 2015 Feb; 372(8):735-46. PubMed ID: 25693013
[TBL] [Abstract][Full Text] [Related]
6. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
[TBL] [Abstract][Full Text] [Related]
7. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
8. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma.
Holland KE; Frieden IJ; Frommelt PC; Mancini AJ; Wyatt D; Drolet BA
Arch Dermatol; 2010 Jul; 146(7):775-8. PubMed ID: 20644039
[TBL] [Abstract][Full Text] [Related]
10. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
[TBL] [Abstract][Full Text] [Related]
11. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment during initiation and maintenance of propranolol therapy for infantile hemangiomas.
Babiak-Choroszczak L; Giżewska-Kacprzak K; Dawid G; Gawrych E; Bagłaj M
Adv Clin Exp Med; 2019 Mar; 28(3):375-384. PubMed ID: 30659785
[TBL] [Abstract][Full Text] [Related]
13. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
14. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature.
Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four-hour hospitalization for patients initiating systemic propranolol therapy for infantile hemangiomas--is it indicated?
Liu LS; Sokoloff D; Antaya RJ
Pediatr Dermatol; 2013; 30(5):554-60. PubMed ID: 23829941
[TBL] [Abstract][Full Text] [Related]
17. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of superficial infantile hemangiomas with topical propranolol].
Niu JN; Xu GQ; Lü RR; Huo R
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
[TBL] [Abstract][Full Text] [Related]
19. Failure of intralesional propranolol in infantile hemangiomas.
Torres-Pradilla M; Baselga E
Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
[TBL] [Abstract][Full Text] [Related]
20. β-blockers for infantile hemangiomas: a single-institution experience.
Blatt J; Morrell DS; Buck S; Zdanski C; Gold S; Stavas J; Powell C; Burkhart CN
Clin Pediatr (Phila); 2011 Aug; 50(8):757-63. PubMed ID: 21525081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
